Position in DYN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$69,998,276
+$11,012,814 QoQ
Shares Held
3,151,656
-3.1% QoQ
Ownership
1.69%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 245 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. DYN ranks #23 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in DYN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,998,276 | 3,151,656 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $58,985,462 | 3,253,473 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $69,436,217 | 3,549,909 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $42,570,345 | 3,365,245 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $29,386,132 | 3,086,779 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $26,477,530 | 2,531,313 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $2,317,996 | 98,387 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $3,654,857 | 101,750 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $3,441,265 | 97,514 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $1,543,562 | 54,370 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $551,722 | 41,483 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $3,030,037 | 338,174 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $400,634 | 35,612 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $309,530 | 26,869 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $235,347 | 20,444 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $555,954 | 43,776 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $242,647 | 35,320 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $268,549 | 27,858 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $449,892 | 37,838 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,521,411 | 93,683 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $333,441 | 15,848 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $157,923 | 10,169 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $133,980 | 6,380 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||